Atlas Venture Life Science Advisors, LLC Portfolio Holdings
Atlas Venture Life Science Advisors, LLC
- $443 Million
- Q3 2025
Atlas Venture Life Science Advisors, LLC has filed its 13F form on November 13, 2025 for Q3 2025 where it was disclosed a total value porftolio of $443 Million distributed in 9 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Kymera Therapeutics, Inc. with a value of $277M, Dyne Therapeutics, Inc. with a value of $116M, Day One Biopharmaceuticals, Inc. with a value of $45.3M, Generation Bio Co. with a value of $5.07M, and Disc Medicine, Inc. with a value of $0.
Examining the 13F form we can see an decrease of $11.6M in the current position value, from $455M to 443M.
Below you can find more details about Atlas Venture Life Science Advisors, LLC portfolio as well as his latest detailed transactions.